Research Article - (2017) Volume 7, Issue 7

Second Generation Tyrosine Kinase Inhibitors Combined With Allogeneic Hematopoietic Stem Cell Transplantation Improve the Prognosis of Patients with Chronic Myelogenous Leukemia in Blast Crisis

Zhengping Yu1, Jia-hua Ding1*, Aining Sun2, Zheng Ge1, Baoan Chen1 and Wenduo He1
1Department of Hematology, Key Department of Jiangsu Medicine, Zhongda Hospital, Medical School, Southeast University, Nanjing, China
2Hematology Division, Suzhou Medical University, Suzhou, China
*Corresponding Author: